Dr Reddy's Laboratories received a Form 483 from the US FDA following an inspection at its Srikakulam, Andhra Pradesh formulations facility (December 4-12, 2025), with 5 observations. The company will address the issues within the stipulated timeline. The stock ended 0.5% higher on Friday, despite a 6% year-to-date decline.
Learn More
Ad
Ad